MX378905B - Pestivirus. - Google Patents

Pestivirus.

Info

Publication number
MX378905B
MX378905B MX2017008096A MX2017008096A MX378905B MX 378905 B MX378905 B MX 378905B MX 2017008096 A MX2017008096 A MX 2017008096A MX 2017008096 A MX2017008096 A MX 2017008096A MX 378905 B MX378905 B MX 378905B
Authority
MX
Mexico
Prior art keywords
virus
relates
proteins
pestivirus
novel
Prior art date
Application number
MX2017008096A
Other languages
English (en)
Other versions
MX2017008096A (es
Inventor
Groof Ad De
Der Hoek Cornelia Maria Van
Lars Guelen
Martin Deijs
Carla Christina Schrier
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2017008096A publication Critical patent/MX2017008096A/es
Publication of MX378905B publication Critical patent/MX378905B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)

Abstract

La presente invención se refiere a un pestivirus de porcino novedoso, a proteínas del virus y a vacunas basadas en el virus y proteínas del mismo; la invención también está relacionada a fragmentos de ADN que comprenden un gen del virus y vacunas de ADN basadas en los genes del virus; además, la invención se relaciona con anticuerpos que son reactivos con el virus novedoso y con pruebas de diagnóstico para la detección del virus o de anticuerpos contra el virus.
MX2017008096A 2014-12-19 2015-12-18 Pestivirus. MX378905B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14199430 2014-12-19
PCT/EP2015/080400 WO2016097245A1 (en) 2014-12-19 2015-12-18 Pestivirus

Publications (2)

Publication Number Publication Date
MX2017008096A MX2017008096A (es) 2017-10-31
MX378905B true MX378905B (es) 2025-03-10

Family

ID=52278411

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008096A MX378905B (es) 2014-12-19 2015-12-18 Pestivirus.

Country Status (13)

Country Link
US (1) US10954491B2 (es)
EP (1) EP3233890B1 (es)
JP (1) JP6772137B2 (es)
KR (1) KR102472939B1 (es)
CN (1) CN107002047B (es)
BR (1) BR112017012484B1 (es)
CA (1) CA2968912A1 (es)
DK (1) DK3233890T3 (es)
ES (1) ES2717544T3 (es)
MX (1) MX378905B (es)
PL (1) PL3233890T3 (es)
RU (1) RU2710041C2 (es)
WO (1) WO2016097245A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
EP3233890B1 (en) * 2014-12-19 2019-02-06 Intervet International B.V. Pestivirus
KR20180042167A (ko) * 2015-08-31 2018-04-25 베링거잉겔하임베트메디카게엠베하 선천성 진전을 위한 페스티바이러스 백신
CN106929606A (zh) * 2017-04-14 2017-07-07 华南农业大学 一种检测鉴定非典型猪瘟病毒（appv）的pcr引物及检测方法与检测试剂盒
CN110041411B (zh) * 2018-01-15 2023-10-03 浙江海隆生物科技有限公司 稳定的非典型猪瘟病毒亚单位蛋白及其疫苗和制备方法和应用
DE102018110208A1 (de) 2018-04-27 2019-10-31 Stiftung Tierärztliche Hochschule Hannover Gentechnisch veränderte Pestiviren und deren Verwendung als Markerimpfstoff
CN110652584A (zh) * 2018-06-29 2020-01-07 西北民族大学 猪瘟弱毒株与猪口蹄疫(o型)灭活抗原二联苗
CN111690778B (zh) * 2020-07-16 2022-06-03 四川农业大学 一种appv病毒的pcr引物、探针及其鉴别方法
CN111733289B (zh) * 2020-07-16 2022-04-05 四川农业大学 用于检测appv、csfv、pcv3和ptv1的引物组、探针及方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2524426C2 (ru) * 2008-12-03 2014-07-27 Пфайзер Инк. ВИРУС ДИАРЕИ КРУПНОГО РОГАТОГО СКОТА С МОДИФИЦИРОВАННЫМ БЕЛКОМ Erns
EP3233890B1 (en) * 2014-12-19 2019-02-06 Intervet International B.V. Pestivirus

Also Published As

Publication number Publication date
CA2968912A1 (en) 2016-06-23
EP3233890B1 (en) 2019-02-06
RU2710041C2 (ru) 2019-12-24
KR102472939B1 (ko) 2022-11-30
MX2017008096A (es) 2017-10-31
JP2018500028A (ja) 2018-01-11
BR112017012484A2 (pt) 2018-02-27
CN107002047B (zh) 2022-02-08
EP3233890A1 (en) 2017-10-25
DK3233890T3 (en) 2019-04-15
RU2017125526A3 (es) 2019-09-23
RU2017125526A (ru) 2019-01-21
ES2717544T3 (es) 2019-06-21
US10954491B2 (en) 2021-03-23
WO2016097245A1 (en) 2016-06-23
US20170342387A1 (en) 2017-11-30
BR112017012484B1 (pt) 2024-02-06
CN107002047A (zh) 2017-08-01
PL3233890T3 (pl) 2019-06-28
JP6772137B2 (ja) 2020-10-21
KR20170098871A (ko) 2017-08-30

Similar Documents

Publication Publication Date Title
MX378905B (es) Pestivirus.
MX2016013584A (es) Parvovirus porcino.
MX2022006652A (es) Proteinas de capside modificadas para un suministro mejorado de vectores de parvovirus.
IL274891A (en) Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
BR112018070260A2 (pt) receptores quiméricos e métodos de uso dos mesmos
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
EA201692539A1 (ru) Антитела и антигенсвязывающие фрагменты, которые специфично связываются с белком тау, ассоциированным с микротрубочками
EA201890527A1 (ru) Терапевтические вакцины против hpv18
EA201791253A1 (ru) Антитела к миостатину, полипептиды, содержащие варианты fc-областей, и способы их применения
EA202192126A3 (ru) Способы сбора культур клеток млекопитающих
DK3176181T3 (da) Anti-ctla4 monoklonal antistof eller antigenbindende fragment deraf, medicinal sammensætning og anvendelse
MX391037B (es) Anticuerpos anti-huntingtina (htt) derivados de humano y usos de los mismos.
MX387400B (es) Células de mamífero que expresan antígenos de citomegalovirus.
BR112016016737A2 (pt) Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma
MX2018012550A (es) Composiciones y metodos para la deteccion de proteinas de celulas huesped.
SG10201806454RA (en) Anti-tenascin c antibodies and uses thereof
BR112015004629A2 (pt) polipeptídeos de clostridium difficile como vacinas
MX2024000004A (es) Proteinas de fusion de inhibidor de tripsina urinaria (uti).
TW201613981A (en) Compositions and methods for the diagnosis of rheumatoid arthritis
NZ731491A (en) Cd83 binding proteins and uses thereof
PH12017501100A1 (en) Recombinant swinepox virus and vaccines
HK1244534A1 (zh) 重组疏螺旋体蛋白及其使用方法
CR20210289A (es) NUEVOS PÉPTIDOS Y NUEVA COMBINACIÓN DE PÉPTIDOS PARA EL USO EN LA INMUNOTERAPIA CONTRA EL CARCINOMA HEPATOCELULAR (CHC) Y OTROS TIPOS DE CÁNCER (Divisional 2017-282)
AR106716A1 (es) Anticuerpos anti-factor d y conjugados
HK1208502A1 (en) Improved safety testing